NL8101531A - Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. - Google Patents

Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. Download PDF

Info

Publication number
NL8101531A
NL8101531A NL8101531A NL8101531A NL8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A
Authority
NL
Netherlands
Prior art keywords
cisplatin
solution
polyethylene glycol
stable
molecular weight
Prior art date
Application number
NL8101531A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8101531A publication Critical patent/NL8101531A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
NL8101531A 1980-03-31 1981-03-27 Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. NL8101531A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US13537380 1980-03-31

Publications (1)

Publication Number Publication Date
NL8101531A true NL8101531A (nl) 1981-10-16

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101531A NL8101531A (nl) 1980-03-31 1981-03-27 Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen.

Country Status (30)

Country Link
JP (1) JPS56152415A (el)
KR (1) KR860000841B1 (el)
AR (1) AR225500A1 (el)
AT (1) AT370996B (el)
AU (1) AU541056B2 (el)
BE (1) BE888209A (el)
CA (1) CA1162479A (el)
CH (1) CH647481A5 (el)
CS (1) CS246051B2 (el)
DD (1) DD157762A5 (el)
DE (1) DE3112272A1 (el)
DK (1) DK158564C (el)
ES (1) ES500869A0 (el)
FI (1) FI70670C (el)
FR (1) FR2480605A1 (el)
GB (1) GB2074028B (el)
GR (1) GR72769B (el)
HU (1) HU183379B (el)
IE (1) IE51070B1 (el)
IL (1) IL62517A (el)
IT (1) IT1170838B (el)
LU (1) LU83270A1 (el)
NL (1) NL8101531A (el)
NO (1) NO156675C (el)
NZ (1) NZ196519A (el)
PH (1) PH17152A (el)
PT (1) PT72774B (el)
SE (1) SE455045B (el)
SU (1) SU1056893A3 (el)
ZA (1) ZA812084B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
AU714992B2 (en) * 1996-08-23 2000-01-13 Alza Corporation Liposomes containing a cisplatin compound
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
EP3773498B1 (en) 2018-03-29 2022-06-22 Project Pharmaceutics GmbH Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
NZ196519A (en) 1983-06-17
PT72774B (en) 1982-11-16
IL62517A0 (en) 1981-05-20
DK158564B (da) 1990-06-11
DK158564C (da) 1990-11-05
IT8148090A0 (it) 1981-03-24
KR830004849A (ko) 1983-07-20
AU541056B2 (en) 1984-12-13
HU183379B (en) 1984-04-28
GB2074028B (en) 1983-09-21
FR2480605A1 (fr) 1981-10-23
IL62517A (en) 1984-01-31
ES8206545A1 (es) 1982-08-16
IT1170838B (it) 1987-06-03
JPS6360008B2 (el) 1988-11-22
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
ZA812084B (en) 1982-04-28
CA1162479A (en) 1984-02-21
PH17152A (en) 1984-06-13
SE455045B (sv) 1988-06-20
JPS56152415A (en) 1981-11-26
DE3112272C2 (el) 1990-09-27
GR72769B (el) 1983-12-02
CS246051B2 (en) 1986-10-16
SU1056893A3 (ru) 1983-11-23
BE888209A (fr) 1981-09-30
NO156675C (no) 1987-11-04
GB2074028A (en) 1981-10-28
AR225500A1 (es) 1982-03-31
FR2480605B1 (el) 1984-05-11
ATA150481A (de) 1982-10-15
IE810715L (en) 1981-09-30
DE3112272A1 (de) 1982-04-29
NO811081L (no) 1981-10-01
PT72774A (en) 1981-04-01
AU6816681A (en) 1981-10-08
FI70670B (fi) 1986-06-26
LU83270A1 (fr) 1981-10-29
AT370996B (de) 1983-05-25
DD157762A5 (de) 1982-12-08
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
ES500869A0 (es) 1982-08-16
DK144281A (da) 1981-10-01
FI70670C (fi) 1986-10-06
IE51070B1 (en) 1986-09-17
SE8101990L (sv) 1981-11-13

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
KR100351713B1 (ko) 백금(ii) 항종양제의 안정용액
US4670262A (en) Novel pharmacological compositions based on Cisplatinum and method for obtaining same
US5023335A (en) 1,2-bis (aminomethyl) cyclobutane-platinum complexes
SE450830B (sv) Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning
NL8101531A (nl) Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen.
FI116058B (fi) Kolme ydintä käsittävät kationiset platinakompleksit, joilla on kasvaimenvastainen vaikutus, sekä niitä sisältävät farmaseuttiset koostumukset
US4544759A (en) Platinum complexes of antitumor agents
FI66121C (fi) Foerfarande foer framstaellning av en stabil vattenloesning v cisplatin
JPS62289591A (ja) テトラヒドロ−３，４−フランジアミン−ｎ，ｎ’−白金錯体
CN1047076C (zh) 稳定的注射剂及注射剂的稳定方法
Mann et al. β β'β"-Triaminotriethylamine and its complex metallic compounds
CZ225590A3 (en) Rebeccamycin analog stable solution and process for preparing thereof
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
JPS60215631A (ja) インタ−ロイキン−２組成物
KR900004404B1 (ko) 유기백금착물 및 이를 사용한 종양 치료방법
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
KR20040060958A (ko) 인터페론-γ 생산 촉진제
WO2019220961A1 (ja) ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤
EP0639978B1 (en) Pharmaceutical combination having antineoplastic activity
JPH0510328B2 (el)
PYRIMIDINE Research & Reviews: Journal of Pharmaceutics and Nanotechnology

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed